State Street’s GeneDx Holdings WGS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$30.3M Buy
472,445
+16,187
+4% +$1.48M ﹤0.01% 2004
2025
Q4
$59.3M Buy
456,258
+16,452
+4% +$2.26M ﹤0.01% 1644
2025
Q3
$47.4M Buy
439,806
+23,810
+6% +$2.59M ﹤0.01% 1747
2025
Q2
$38.4M Buy
415,996
+76,367
+22% +$5.99M ﹤0.01% 1821
2025
Q1
$30.1M Buy
339,629
+19,721
+6% +$1.71M ﹤0.01% 1902
2024
Q4
$24.6M Buy
319,908
+4,994
+2% +$349K ﹤0.01% 2108
2024
Q3
$13.4M Buy
314,914
+48,735
+18% +$1.65M ﹤0.01% 2435
2024
Q2
$6.96M Buy
266,179
+197,037
+285% +$3.73M ﹤0.01% 2766
2024
Q1
$631K Buy
69,142
+10,900
+19% +$65.4K ﹤0.01% 3587
2023
Q4
$160K Sell
58,242
-1,503
-3% -$3.5K ﹤0.01% 3944
2023
Q3
$217K Buy
59,745
+3
+0% +$16 ﹤0.01% 3916
2023
Q2
$356K Sell
59,742
-73,144
-55% -$579K ﹤0.01% 3798
2023
Q1
$1.6M Buy
132,886
+28,999
+28% +$387K ﹤0.01% 3405
2022
Q4
$904K Sell
103,887
-1,937
-2% -$42.7K ﹤0.01% 3583
2022
Q3
$3.06M Buy
105,824
+5,960
+6% +$273K ﹤0.01% 3288
2022
Q2
$4.15M Buy
99,864
+65,393
+190% +$4.44M ﹤0.01% 3190
2022
Q1
$3.49M Buy
34,471
+15,716
+84% +$1.75M ﹤0.01% 3342
2021
Q4
$2.76M Buy
18,755
+7,013
+60% +$1.57M ﹤0.01% 3535
2021
Q3
$2.94M Buy
+11,742
New +$4.03M ﹤0.01% 3502

Other funds holding WGS

State Street's WGS Position: Q1 2026 in Review

State Street increased its GeneDx Holdings (WGS) stake by 3.5% in Q1 2026, buying an estimated $1.48M and bringing the position to 472,445 shares worth $30.3M. The position accounts for ﹤0.01% of the portfolio, ranked #2004.

State Street first reported a position in WGS in Q3 2021 and has held it in 19 quarters since. The position peaked at $59.3M in Q4 2025. 240 funds tracked by Wall St. Rank hold WGS as of Q1 2026.

  • State Street held 472,445 shares of GeneDx Holdings worth $30.3M as of Q1 2026.
  • State Street bought 16,187 GeneDx Holdings shares in Q1 2026, an estimated $1.48M.
  • GeneDx Holdings made up ﹤0.01% of State Street's portfolio in Q1 2026, its #2004 holding.
  • State Street first reported a position in GeneDx Holdings in Q3 2021 and has held it in 19 quarters since.
  • State Street's GeneDx Holdings position peaked at $59.3M in Q4 2025.
  • 240 funds tracked by Wall St. Rank held GeneDx Holdings as of Q1 2026.

Based on State Street's 13F filing for Q1 2026, filed 15 May 2026.